AMDIZALISIB
UNII F3YMY7783P

Substance Identification & Data

This profile provides standardized clinical and technical data for Amdizalisib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) F3YMY7783P.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1894229-05-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

F3YMY7783P

CAS Registry Number

1894229-05-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

AMDIZALISIB

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C19H15ClN8

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

WKDBRCUUDXLTIM-NSHDSACASA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C148532

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

118981804

Unique identification number in the NCBI database of chemical substances.

INN ID

11744

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

LM-19

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1nc(c(c(n1)N)C#N)N[C@@H](C)c2cc3n(c(cn3)Cl)nc2-c4ccccc4

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Amdizalisib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.